Yuan M. Jian

State Key Laboratory Of Digestive Health
Beijing, 100050, China

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 44 publications

Proportion and clinical characteristics of probable metabolic-associated fatty liver disease-related cirrhosis in cryptogenic cirrhosis

Proportion and clinical characteristics of probable metabolic-associated fatty liver disease-related cirrhosis in cryptogenic cirrhosis

Journal: Zhonghua gan zang bing za zhi = Zhonghua ganzangbing zazhi = Chinese journal of hepatology

Published: September 07, 2026

Deep molecular remission and encouraging survival without transplantation: V-CAG for arsenic-resistant relapsed APL.

Deep molecular remission and encouraging survival without transplantation: V-CAG for arsenic-resistant relapsed APL.

Journal: British journal of haematology

Published: June 14, 2026

Venetoclax, azacitidine, and G-CSF targeting molecular residual disease in CBFB::MYH11 AML resistant to high-dose cytarabine.

Venetoclax, azacitidine, and G-CSF targeting molecular residual disease in CBFB::MYH11 AML resistant to high-dose cytarabine.

Journal: Blood cancer journal

Published: March 30, 2026

Psychometric Evaluation of the Chinese Version of the Quality-of-Life Questionnaire for Patients with Multiple Myeloma.

Psychometric Evaluation of the Chinese Version of the Quality-of-Life Questionnaire for Patients with Multiple Myeloma.

Journal: Palliative medicine reports

Published: December 31, 2024

Clinical Characteristics and Prognostic Value of Circulating Plasma Cells in Newly Diagnosed Multiple Myeloma Patients in China.

Clinical Characteristics and Prognostic Value of Circulating Plasma Cells in Newly Diagnosed Multiple Myeloma Patients in China.

Journal: Journal of blood medicine

Published: December 30, 2024

Analysis of the prognostic factors in primary plasma cell leukemia in the era of novel agents

Analysis of the prognostic factors in primary plasma cell leukemia in the era of novel agents

Journal: Zhonghua xue ye xue za zhi = Zhonghua xueyexue zazhi

Published: September 04, 2024

A new prognostic scoring system for newly diagnosed multiple myeloma in the era of new drugs.

A new prognostic scoring system for newly diagnosed multiple myeloma in the era of new drugs.

Journal: Frontiers in medicine

Published: July 30, 2024

Is t(11;14) in newly diagnosed multiple myeloma a favorable outcome in the novel agent era?

Is t(11;14) in newly diagnosed multiple myeloma a favorable outcome in the novel agent era?

Journal: Blood research

Published: July 29, 2024

Endovascular recanalization of symptomatic long-segment nonacute vertebral artery occlusion: a case report.

Endovascular recanalization of symptomatic long-segment nonacute vertebral artery occlusion: a case report.

Journal: BMC neurology

Published: July 22, 2024

Paired comparisons of venetoclax concentration in cerebrospinal fluid, bone marrow, and plasma in acute leukemia patients.

Paired comparisons of venetoclax concentration in cerebrospinal fluid, bone marrow, and plasma in acute leukemia patients.

Journal: Clinical and translational science

Published: April 28, 2024

Chromosome 1q21 Aberrations Are Poor Prognostic Factors for Newly Diagnosed Multiple Myeloma Patients.

Chromosome 1q21 Aberrations Are Poor Prognostic Factors for Newly Diagnosed Multiple Myeloma Patients.

Journal: Journal of clinical laboratory analysis

Published: March 03, 2024

Prognostic value of the Second Revision of the International Staging System in patients with newly diagnosed transplant-eligible multiple myeloma

Prognostic value of the Second Revision of the International Staging System in patients with newly diagnosed transplant-eligible multiple myeloma

Journal: Zhonghua nei ke za zhi

Published: January 08, 2024

Showing 1-12 of 44

Last Updated: 09/26/2026